Prognosis
Moderna Booster Backed by U.S. Panel; Biden’s Plea: Virus Update
This article is for subscribers only.
Booster shots of Moderna Inc.’s vaccine should be given to older people and those at high risk of the disease, a U.S. Food and Drug Administration advisory panel said.
Another FDA panel will take up Merck & Co.’s emergency use authorization request for its Covid-19 pill on Nov. 30, taking the data into a public forum to discuss any safety concerns.